although vaccine antibiotic could kill inhibit micro mani infect disease remain difficult treat acquire resist adverse side effect nanocarriersbas technology made signifies progress long time introduce new paradigm drug delivery howe still challenge like lack specify toward target site nanocarri until ligand surface call active target provide promise way sold problem accuser area prevent toxic sideeffect mini review demons recent studi use target strategy four common eg liposom nanoparticles denim carbon nanotube deli encapsul drug introduce 